Genmab | GEN - PE Price to Earnings

Stock Price
1,713.00
Daily Change
-1.50 -0.09%
Monthly
-6.14%
Yearly
23.33%
Q1 Forecast
1,614.31

Genmab reported 12.75 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Almirall 79.43 0.3 Dec/2025
Amarin 91.05 88.3 Jun/2023
Amgen 25.31 15.82 Dec/2025
argenx SE 43.02 11.67 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bayer 5.93 0.68 Sep/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Demant 27.46 7.1 Dec/2025
Exelixis 602.31 586.25 Dec/2025
Fresenius Medical Care 8.71 1.86 Dec/2025
Galapagos 3.14 50.78 Dec/2025
Genmab 12.75 0.62 Sep/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
GN Store Nord 16.87 3.58 Sep/2025
GRIFOLS 16.81 28.19 Sep/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lonza 67.52 12.2 Jun/2024
Merck 20.56 7.18 Dec/2025
Novartis 15.74 0.15 Sep/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
UCB 35.22 3.9 Jun/2025